Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Mol Oncol. 2014 Jul 3;8(8):1626–1639. doi: 10.1016/j.molonc.2014.06.013

Figure 6. DMBA-induced alterations in MMP-9, MMP-7 and E-cadherin.

Figure 6

WT and BK5.EP4 transgenic mice (n= 3 each) were treated with 400 μg DMBA, sacrificed after 24 and 48 h and after 5 days and processed for IHC (200× magnification). A. Representative skin sections stained with an antibody against MMP-9 48 h after treatment. B. Representative skin sections stained with an antibody against MMP-7 24 h after treatment. C. Representative skin section stained with an antibody against E-cadherin 24 h after treatment.